Work

HSR25-167: Real-World Study Demonstrates Lack of Biomarker-driven Care in First-Line Treatment for Advanced/Metastatic Non-Small Cell Lung Cancer That Received Next-Generation Sequencing Testing

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of the National Comprehensive Cancer Network

DOI: 10.6004/jnccn.2024.7275

Authors: Melina E. Marmarelis, Adrienne M. Gilligan, Tomoko Sugihara, Shen Zheng, Tyler Marquart, Sam Whipple, Naleen Raj Bhandari, Charu Aggarwal

Institutions: Eli Lilly (United States), Syneos Health (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4408958794

FWCI: 0.608

Cites:

Cited by: 1

Related to: 10